Table 1 From Phase I Targeted Systemic Exposure Study Of Paclitaxel In

Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 1 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 1 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 1 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 3 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 3 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 1 from Targeted Oral Delivery of Paclitaxel Using Colostrum ...
Table 1 from Targeted Oral Delivery of Paclitaxel Using Colostrum ...
(PDF) Phase I study of sapanisertib with carboplatin and paclitaxel in ...
(PDF) Phase I study of sapanisertib with carboplatin and paclitaxel in ...
Table 1 from Targeted Oral Delivery of Paclitaxel Using Colostrum ...
Table 1 from Targeted Oral Delivery of Paclitaxel Using Colostrum ...
(PDF) A phase I study of TAK-659 and paclitaxel in patients with taxane ...
(PDF) A phase I study of TAK-659 and paclitaxel in patients with taxane ...
Table 1 from A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib ...
Table 1 from A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib ...
Table 1 from Phase II study of the combination of cetuximab and weekly ...
Table 1 from Phase II study of the combination of cetuximab and weekly ...
Table 1 from Mortality Not Correlated With Paclitaxel Exposure An ...
Table 1 from Mortality Not Correlated With Paclitaxel Exposure An ...
Table 1 from Randomized phase III study comparing paclitaxel/cisplatin ...
Table 1 from Randomized phase III study comparing paclitaxel/cisplatin ...
Table 1 from Prospective Study Testing a Simplified Paclitaxel ...
Table 1 from Prospective Study Testing a Simplified Paclitaxel ...
(PDF) Phase I and Pharmacokinetic Study of Sequential Paclitaxel and ...
(PDF) Phase I and Pharmacokinetic Study of Sequential Paclitaxel and ...
(PDF) Phase I and Pharmacological Study of Paclitaxel Given Over 3 h ...
(PDF) Phase I and Pharmacological Study of Paclitaxel Given Over 3 h ...
Phase I pharmacokinetic study of a weekly liposomal paclitaxel ...
Phase I pharmacokinetic study of a weekly liposomal paclitaxel ...
Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion ...
Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion ...
Effect of oral drug dose on the systemic exposure to paclitaxel in ...
Effect of oral drug dose on the systemic exposure to paclitaxel in ...
Figure 1 from A First-Time-In-Human Phase I Clinical Trial of ...
Figure 1 from A First-Time-In-Human Phase I Clinical Trial of ...
Figure 1 from A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib ...
Figure 1 from A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib ...
(PDF) Phase I trial and pharmacological study of a 3-hour paclitaxel ...
(PDF) Phase I trial and pharmacological study of a 3-hour paclitaxel ...
Phase I results of a phase I/II study of weekly nab-paclitaxel in ...
Phase I results of a phase I/II study of weekly nab-paclitaxel in ...
(PDF) A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein ...
(PDF) A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein ...
Figure 1 from Study protocol of a phase II clinical trial evaluating ...
Figure 1 from Study protocol of a phase II clinical trial evaluating ...
Table 1 from Short and Long-Term Effects of the Exposure of Breast ...
Table 1 from Short and Long-Term Effects of the Exposure of Breast ...
Table I. | Phase II Study of Weekly Paclitaxel as a Second-line ...
Table I. | Phase II Study of Weekly Paclitaxel as a Second-line ...
Figure 1. | Phase I Study of Combination Chemotherapy Consisting of ...
Figure 1. | Phase I Study of Combination Chemotherapy Consisting of ...
Preclinical Development and Phase I Study of ZSYY001, a Polymeric ...
Preclinical Development and Phase I Study of ZSYY001, a Polymeric ...
An open-label, phase IB/II study of abemaciclib with paclitaxel for ...
An open-label, phase IB/II study of abemaciclib with paclitaxel for ...
Figure 1 from The Safety and Efficacy of Weekly Paclitaxel ...
Figure 1 from The Safety and Efficacy of Weekly Paclitaxel ...
A randomized phase 2 study of sapanisertib in combination with ...
A randomized phase 2 study of sapanisertib in combination with ...
Selected phase II/III studies of weekly single-agent paclitaxel in ...
Selected phase II/III studies of weekly single-agent paclitaxel in ...
Table 1 from Survival Analysis and Clinical Outcomes between Paclitaxel ...
Table 1 from Survival Analysis and Clinical Outcomes between Paclitaxel ...
(PDF) Phase I/II Clinical Study of Pulsed Paclitaxel Radiosensitization ...
(PDF) Phase I/II Clinical Study of Pulsed Paclitaxel Radiosensitization ...

Loading image details...

Source
Dimensions